Tag: Havn Life - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

Post published:February 24, 2022
Post category:Press Release

Read more about the article HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market

HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market

Post published:February 17, 2022
Post category:Press Release

Read more about the article HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.

Post published:December 20, 2021
Post category:Press Release

Read more about the article HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes

HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes

Post published:December 13, 2021
Post category:Press Release

Read more about the article HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

Post published:November 22, 2021
Post category:Press Release

Read more about the article HAVN Life Announces Departure of Rick Brar as Director

HAVN Life Announces Departure of Rick Brar as Director

Post published:October 25, 2021
Post category:Press Release

Read more about the article Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Post published:March 25, 2021
Post category:Press Release

Read more about the article Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Post published:February 2, 2021
Post category:Press Release

Read more about the article Havn Life to Support Canadian Counterpart of Veterans’ Organization, Heroic Hearts

Havn Life to Support Canadian Counterpart of Veterans’ Organization, Heroic Hearts

Post published:January 18, 2021
Post category:Press Release

Read more about the article Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing

Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing

Post published:January 7, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.